Advertisement

Vascular Anomalies

  • Sheilagh M. MaguinessEmail author
  • Christina L. Boull
Chapter
  • 921 Downloads

Abstract

Vascular anomalies represent a diverse group of entities, each with unique natural history and associated complications. To meet the needs of this challenging population, many referral centers now have interdisciplinary clinics devoted specifically to vascular lesions.

Keywords

Infantile hemangioma Kaposiform hemangioendothelioma Kasabach–Merritt phenomenon Localized intravascular coagulopathy LUMBAR syndrome Propranolol Rapidly involuting congenital hemangioma Sirolimus Venous malformation Multifocal lymphangioendotheliomatosis Glomuvenous malformation Blue rubber bleb nevus syndrome 

References

  1. 1.
    Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg. 1982;70(1):120–1.CrossRefPubMedGoogle Scholar
  2. 2.
    Croteau SE, Liang MG, Kozakewich HP, Alomari AI, Fishman SJ, Mulliken JB, Trenor 3rd CC. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Drolet BA, Trenor 3rd CC, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285–91.CrossRefPubMedGoogle Scholar
  4. 4.
    Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, Taïeb A, Stalder JF, Escande JP. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997;130(4):631–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg. 1997;100(6):1377–86.CrossRefPubMedGoogle Scholar
  6. 6.
    Paller AS, Mancini AJ. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. Philadelphia: Elsevier; 2011.Google Scholar
  7. 7.
    Gruman A, Liang MG, Mulliken JB, Fishman SJ, Burrows PE, Kozakewich HP, Blei F, Frieden IJ. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 2005;52(4):616–22.CrossRefPubMedGoogle Scholar
  8. 8.
    O’Rafferty C, O’Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol. 2015;171(1):38–51.CrossRefPubMedGoogle Scholar
  9. 9.
    Osio A, Fraitag S, Hadj-Rabia S, Bodemer C, de Prost Y, Hamel-Teillac D. Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature. Arch Dermatol. 2010;146(7):758–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Kai L, Wang Z, Yao W, Dong K, Xiao X. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma. J Cancer Res Clin Oncol. 2014;140(3):471–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Blatt J, Stavas J, Moats-Staats B, Woosley J, Morrell DS. Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer. 2010;55(7):1396–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Greene AK, Liu AS, Mulliken JB, Chalache K, Fishman SJ. Vascular anomalies in 5,621 patients: guidelines for referral. J Pediatr Surg. 2011;46(9):1784–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Mathes EF, Haggstrom AN, Dowd C, Hoffman WY, Frieden IJ. Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic. Arch Dermatol. 2004;140(8):979–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68(2):198–201.CrossRefPubMedGoogle Scholar
  15. 15.
    Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee A, Driscoll D, Gloviczki P, Clay R, Shaughnessy W, Stans A. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review. Pediatrics. 2005;115(3):744–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbé D, Barrellier MT, Vanwijck R, Vikkula M, Boon LM. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Rodríguez-Mañero M, Aguado L, Redondo P. Pulmonary arterial hypertension in patients with slow-flow vascular malformations. Arch Dermatol. 2010;146(12):1347–52.CrossRefPubMedGoogle Scholar
  19. 19.
    Nguyen JT, Koerper MA, Hess CP, Dowd CF, Hoffman WY, Dickman M, Frieden IJ. Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences. Pediatr Dermatol. 2014;31(5):556–60.CrossRefPubMedGoogle Scholar
  20. 20.
    Maguiness S, Koerper M, Frieden I. Relevance of D-dimer testing in patients with venous malformations. Arch Dermatol. 2009;145(11):1321–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Lance EI, Sreenivasan AK, Zabel TA, Kossoff EH, Comi AM. Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes. J Child Neurol. 2013;28(2):213–8.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138(12):1567–76.CrossRefPubMedGoogle Scholar
  23. 23.
    Suh KY, Frieden IJ. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol. 2010;146(9):971–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Johnson EF, Smidt AC. Not just a diaper rash: LUMBAR syndrome. J Pediatr. 2014;164(1):208–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Stockman A, Boralevi F, Taïeb A, Léauté-Labrèze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology. 2007;214(1):40–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Girard C, Bigorre M, Guillot B, Bessis D. PELVIS syndrome. Arch Dermatol. 2006;142(7):884–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Iacobas I, Burrows PE, Frieden IJ, Liang MG, Mulliken JB, Mancini AJ, Kramer D, Paller AS, Silverman R, Wagner AM, Metry DW. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157(5):795–801.CrossRefPubMedGoogle Scholar
  28. 28.
    Drolet BA, Chamlin SL, Garzon MC, Adams D, Baselga E, Haggstrom AN, Holland KE, Horii KA, Juern A, Lucky AW, Mancini AJ, McCuaig C, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Frieden IJ. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr. 2010;157(5):789–94.CrossRefPubMedGoogle Scholar
  29. 29.
    de Graaf M, Pasmans SG, van Drooge AM, Nievelstein RA, Gooskens RH, Raphael MF, Breugem CC. Associated anomalies and diagnostic approach in lumbosacral and perineal haemangiomas: case report and review of the literature. J Plast Reconstr Aesthet Surg. 2013;66(1):e26–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Willihnganz-Lawson K, Gordon J, Perkins J, Shnorhavorian M. Genitourinary and perineal vascular anomalies in children: a Seattle children’s experience. J Pediatr Urol. 2015;11(4):227.e1–6.CrossRefGoogle Scholar
  31. 31.
    Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146(11):1235–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Maguiness SM, Frieden IJ. Management of difficult infantile haemangiomas. Arch Dis Child. 2012;97(3):266–71.CrossRefPubMedGoogle Scholar
  33. 33.
    Thomas J, Kumar P, Kumar DD. Ulcerated infantile haemangioma of buttock successfully treated with topical timolol. J Cutan Aesthet Surg. 2013;6(3):168–9.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Michel JL, Patural H. Response to oral propranolol therapy for ulcerated hemangiomas in infancy. Arch Pediatr. 2009;16(12):1565–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.CrossRefPubMedGoogle Scholar
  36. 36.
    Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30(2):182–91.CrossRefPubMedGoogle Scholar
  37. 37.
    Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol. 2002;19(1):5–11.CrossRefPubMedGoogle Scholar
  38. 38.
    Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001;107(7):1647–54.CrossRefPubMedGoogle Scholar
  39. 39.
    Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, Burrows PE, Perez-Atayde AR, Kozakewich HP. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003;6(6):495–510.CrossRefPubMedGoogle Scholar
  40. 40.
    Nasseri E, Piram M, McCuaig CC, Kokta V, Dubois J, Powell J. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 2014;70(1):75–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Boon LM, Enjolras O, Mulliken JB. Congenital hemangioma: evidence of accelerated involution. J Pediatr. 1996;128(3):329–35.CrossRefPubMedGoogle Scholar
  42. 42.
    Maguiness S, Uihlein LC, Liang MG, Kozakewich H, Mulliken JB. Rapidly involuting congenital hemangioma with fetal involution. Pediatr Dermatol. 2015;32(3):321–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Elia D, Garel C, Enjolras O, Vermouneix L, Soupre V, Oury JF, Guibaud L. Prenatal imaging findings in rapidly involuting congenital hemangioma of the skull. Ultrasound Obstet Gynecol. 2008;31(5):572–5.CrossRefPubMedGoogle Scholar
  44. 44.
    Fadell 2nd MF, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2011;41(8):1057–60.CrossRefPubMedGoogle Scholar
  45. 45.
    Vildy S, Macher J, Abasq-Thomas C, Le Rouzic-Dartoy C, Brunelle F, Hamel-Teillac D, Duteille F, Perret C, Perrot P, Cassagnau E, Chauty-Frondas A, Aubert H, Barbarot S. Life-threatening hemorrhaging in neonatal ulcerated congenital hemangioma: two case reports. JAMA Dermatol. 2015;151(4):422–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009;44(1):125–33.CrossRefPubMedGoogle Scholar
  47. 47.
    Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg. 2012;47(1):165–70.CrossRefPubMedGoogle Scholar
  48. 48.
    Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, Paltiel HJ, Klement G, Mulliken JB, Fishman SJ. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007;42(1):62–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Boon LM, Burrows PE, Paltiel HJ, Lund DP, Ezekowitz RA, Folkman J, Mulliken JB. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996;129(3):346–54.CrossRefPubMedGoogle Scholar
  50. 50.
    Zenzen W, Perez-Atayde AR, Elisofon SA, Kim HB, Alomari AI. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol. 2009;39(10):1118–23.CrossRefPubMedGoogle Scholar
  51. 51.
    North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity. Arch Dermatol. 2004;140(5):599–606.CrossRefPubMedGoogle Scholar
  52. 52.
    Prasad V, Fishman SJ, Mulliken JB, Fox VL, Liang MG, Klement G, Kieran MW, Burrows PE, Waltz DA, Powell J, Dubois J, Levy ML, Perez-Atayde AR, Kozakewich HP. Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol. 2005;8(4):407–19.CrossRefPubMedGoogle Scholar
  53. 53.
    Marron M, Catrine K, North P, Browning MB, Kerschner JE, Noel R, Drolet BA, Kelly M. Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer. 2009;52(4):531–4.CrossRefGoogle Scholar
  54. 54.
    Glick ZR, Frieden IJ, Garzon MC, Mully TW, Drolet BA. Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol. 2012;67(5):898–903.CrossRefPubMedGoogle Scholar
  55. 55.
    Nahm WK1, Moise S, Eichenfield LF, Paller AS, Nathanson L, Malicki DM, Friedlander SF. Venous malformations in blue rubber bleb nevus syndrome: variable onset of presentation. J Am Acad Dermatol. 2004 May;50(5 Suppl):S101-6.Google Scholar
  56. 56.
    Esparza EM, Deutsch G, Stanescu L, Weinberger E, Brandling-Bennett HA, Sidbury R. Multifocal lymphangioendotheliomatosis with thrombocytopenia: phenotypic variant and course with propranolol, corticosteroids, and aminocaproic acid. J Am Acad Dermatol. 2012;67(1):e62–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Kline RM, Buck LM. Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer. 2009;52(4):534–6.CrossRefPubMedGoogle Scholar
  58. 58.
    Droitcourt C, Boccara O, Fraitag S, Favrais G, Dupuy A, Maruani A. Multifocal lymphangioendotheliomatosis with thrombocytopenia: clinical features and response to sirolimus. Pediatrics. 2015;136(2):e517–22.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Divison of Pediatric Dermatology, Department of DermatologyUniversity of MinnesotaMinneapolisUSA

Personalised recommendations